ArticleJournal of managed care & specialty pharmacy2023

Comparative value of dapagliflozin vs empagliflozin in patients with heart failure and preserved ejection fraction: A cost-effectiveness analysis.

Amey Rane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.